The money for drug development would come from the same budgets that currently pay for drug purchases - the manufacturing expenses are only a small fraction of what they pay now, and the remainder of those budgets should get shifted to R&D.

Medicare alone spends something like $50B per year on drugs, add also Medicaid and other agencies (VA and such), and there you have an ability to invest comparable numbers as the pharma companies do currently.